Market icon

Will there be a variant that overtakes Omicron in the US by...?

Market icon

Will there be a variant that overtakes Omicron in the US by...?

$13,667 Vol.

Feb 15, 2022
Polymarket

$13,667 Vol.

Polymarket
Market icon

By February 15th?

$880 Vol.

No

Market icon

By March 15th?

$3,723 Vol.

No

Market icon

By April 19th?

$6,561 Vol.

No

Market icon

By May 17th?

$2,503 Vol.

No

This is a market on whether there will be a variant that overtakes the Omicron variant in the US by February 15, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before February 15, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on February 15, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by March 15, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before March 15, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on March 15, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by April 19, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before April 19, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on April 19, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by May 17, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before May 17, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on May 17, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.

This is a market on whether there will be a variant that overtakes the Omicron variant in the US by February 15, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before February 15, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on February 15, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by March 15, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before March 15, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on March 15, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by April 19, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before April 19, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on April 19, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by May 17, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before May 17, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on May 17, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.

Vorsicht bei externen Links.

Häufig gestellte Fragen

„Will there be a variant that overtakes Omicron in the US by...?" ist ein Prognosemarkt auf Polymarket mit 4 möglichen Ergebnissen, bei dem Händler Anteile auf Basis ihrer Einschätzung kaufen und verkaufen. Das aktuell führende Ergebnis ist „By February 15th?" mit 0%, gefolgt von „By March 15th?" mit 0%. Die Preise spiegeln Echtzeit-Wahrscheinlichkeiten der Community wider. Ein Anteilspreis von 0¢ bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 0% zuweist. Diese Quoten ändern sich laufend, wenn Händler auf neue Entwicklungen reagieren. Anteile am richtigen Ergebnis können bei Marktauflösung für jeweils $1 eingelöst werden.

Stand heute hat „Will there be a variant that overtakes Omicron in the US by...?" ein Gesamthandelsvolumen von $13.7K generiert, seit der Markt am Jan 11, 2022 gestartet wurde. Dieses Aktivitätsniveau spiegelt starkes Engagement der Polymarket-Community wider und stellt sicher, dass die aktuellen Quoten von einem breiten Pool an Marktteilnehmern geprägt werden. Sie können Live-Preisbewegungen verfolgen und direkt auf dieser Seite auf jedes Ergebnis handeln.

Um auf „Will there be a variant that overtakes Omicron in the US by...?" zu handeln, durchsuchen Sie die 4 verfügbaren Ergebnisse auf dieser Seite. Jedes Ergebnis zeigt einen aktuellen Preis, der die implizierte Wahrscheinlichkeit des Marktes darstellt. Um eine Position einzunehmen, wählen Sie das Ergebnis, das Sie für am wahrscheinlichsten halten, wählen Sie „Ja" um dafür oder „Nein" um dagegen zu handeln, geben Sie Ihren Betrag ein und klicken Sie auf „Handeln". Liegt Ihr gewähltes Ergebnis bei Marktauflösung richtig, zahlen Ihre „Ja"-Anteile jeweils $1 aus. Liegt es falsch, zahlen sie $0. Sie können Ihre Anteile auch jederzeit vor der Auflösung verkaufen.

Dies ist ein offener Markt. Der aktuelle Spitzenreiter für „Will there be a variant that overtakes Omicron in the US by...?" ist „By February 15th?" mit nur 0%, dicht gefolgt von „By March 15th?" mit 0%. Da kein Ergebnis eine starke Mehrheit hat, sehen Händler dies als hochgradig unsicher an, was einzigartige Handelsmöglichkeiten bieten kann. Diese Quoten werden in Echtzeit aktualisiert – speichern Sie diese Seite als Lesezeichen.

Die Auflösungsregeln für „Will there be a variant that overtakes Omicron in the US by...?" definieren genau, was passieren muss, damit jedes Ergebnis als Gewinner erklärt wird – einschließlich der offiziellen Datenquellen zur Bestimmung des Ergebnisses. Sie können die vollständigen Auflösungskriterien im Abschnitt „Regeln" auf dieser Seite über den Kommentaren einsehen. Wir empfehlen, die Regeln vor dem Handeln sorgfältig zu lesen, da sie die genauen Bedingungen, Sonderfälle und Quellen festlegen.